LIVN (STOCKS)
LivaNova PLC Ordinary Shares
$66.430000
-0.300000 (-0.45%)
Prev close: $66.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vladimir A. Makatsaria
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,638.90M
- Employees
- 2,900
- P/E (TTM)
- -16.56
- P/B (TTM)
- 3.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$1.11 | $0.94 | +0.1726 | +18.41% |
|
Jun 2025 (Q2)
|
$1.05 | $0.87 | +0.1773 | +20.32% |
|
Mar 2025 (Q1)
|
$0.88 | $0.78 | +0.1023 | +13.15% |
|
Dec 2024 (Q4)
|
$0.81 | $0.82 | -0.0073 | -0.89% |
Financial Statements
| Revenues | $1.35B |
| Benefits Costs and Expenses | $1.54B |
| Cost Of Revenue | $434.50M |
| Costs And Expenses | $1.54B |
| Gross Profit | $914.47M |
| Operating Expenses | $742.54M |
| Selling, General, and Administrative Expenses | $536.09M |
| Research and Development | $176.95M |
| Other Operating Expenses | $7.60M |
| Operating Income/Loss | $193.83M |
| Income/Loss Before Equity Method Investments | -$191.94M |
| Income/Loss From Continuing Operations After Tax | -$217.45M |
| Income/Loss From Continuing Operations Before Tax | -$191.94M |
| Income/Loss From Equity Method Investments | -$41.00K |
| Income Tax Expense/Benefit | $25.51M |
| Income Tax Expense/Benefit, Deferred | $1.77M |
| Net Income/Loss | -$217.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$217.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$217.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.99 |
| Diluted Earnings Per Share | -$3.99 |
| Basic Average Shares | 163,674,000 |
| Diluted Average Shares | 164,330,000 |
| Assets | $2.56B |
| Current Assets | $1.10B |
| Inventory | $167.54M |
| Other Current Assets | $929.61M |
| Noncurrent Assets | $1.46B |
| Fixed Assets | $218.51M |
| Intangible Assets | $234.53M |
| Other Non-current Assets | $1.01B |
| Liabilities | $1.40B |
| Current Liabilities | $827.59M |
| Accounts Payable | $88.16M |
| Other Current Liabilities | $739.43M |
| Noncurrent Liabilities | $572.77M |
| Long-term Debt | $434.45M |
| Other Non-current Liabilities | $138.31M |
| Equity | $1.16B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.16B |
| Liabilities And Equity | $2.56B |
| Net Cash Flow From Operating Activities | $250.65M |
| Net Cash Flow From Operating Activities, Continuing | $250.65M |
| Net Cash Flow From Investing Activities | -$53.36M |
| Net Cash Flow From Investing Activities, Continuing | -$53.36M |
| Net Cash Flow From Financing Activities | -$226.22M |
| Net Cash Flow From Financing Activities, Continuing | -$226.22M |
| Exchange Gains/Losses | $8.43M |
| Net Cash Flow | -$20.50M |
| Net Cash Flow, Continuing | -$28.93M |
| Comprehensive Income/Loss | -$185.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$185.28M |
| Other Comprehensive Income/Loss | -$185.28M |
| Other Comprehensive Income/Loss Attributable To Parent | $32.21M |